Lysosome activable polymeric vorinostat encapsulating PD-L1KD for a combination of HDACi and immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lysosome activable polymeric vorinostat encapsulating PD-L1KD for a combination of HDACi and immunotherapy

Published:2021-01-01 Issue:1 Volume:28 Page:963-972
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Lu Fengkun¹,Hou Lei¹,Wang Sizhen²,Yu Yingjie²,Zhang Yunchang²,Sun Linhong²,Wang Chen³,Ma Zhiqiang²,Yang Feng¹²

Affiliation:

1. Department of Pharmacy, Hebei North University Hebei Key Laboratory of Neuropharmacology, Zhangjiakou, People’s Republic of China

2. School of Pharmacy, Second Military Medical University, Shanghai, People’s Republic of China

3. Department of Oncology, Ruijin North Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2021.1927246

Reference48 articles.

1. Histone deacetylase inhibitors vorinostat and panobinostat induce G1 cell cycle arrest and apoptosis in multidrug resistant sarcoma cell lines

2. FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy

3. HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

4. Histone Deacetylase Inhibitors: Overview and Perspectives

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histone deacetylase inhibitor and PD‑1 blockade synergistically inhibit B‑cell lymphoma progression in mice model by promoting T‑cell infiltration and apoptosis;Oncology Reports;2024-08-07

2. A dual-prodrug nanogel combining Vorinostat and Pyropheophorbide a for a high efficient photochemotherapy;International Journal of Pharmaceutics;2024-08

3. Advances in targeting histone deacetylase for treatment of solid tumors;Journal of Hematology & Oncology;2024-05-31

4. Qntrolling the LncRNA HULC-Tregs-PD-1 axis inhibits immune escape in the tumor microenvironment;Heliyon;2024-04

5. Nano-based vaccination and their administration routes in cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3